Most patients (n = 78; 85.7%) had prior diagnosis of
cancer, being the most common hematologic malignan- cies (n =
21; 23.1%), breast cancer (n = 13; 14.3%) and lung
cancer (n = 8; 8.8%). At least, 25 patients (27.5%)
were undergoing oncologic treatment (chemotherapy, im- munotherapy or radiotherapy) in
the moment of the exam. Other comorbidities were present in
17 patients (18.7%), the more common were cardiopathy and pneumopathy
in 6 cases (6.6%) each.